489 related articles for article (PubMed ID: 10160112)
41. Pharmacoeconomics: disease-based management applications.
Garrelts JC
Pharm Pract Manag Q; 1996 Jul; 16(2):36-40. PubMed ID: 10161609
[TBL] [Abstract][Full Text] [Related]
42. Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committees.
Langley PC
Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S24-6. PubMed ID: 7552914
[No Abstract] [Full Text] [Related]
43. The arrival of economic evidence in managed care formulary decisions: the unsolicited request process.
Neumann PJ
Med Care; 2005 Jul; 43(7 Suppl):27-32. PubMed ID: 16056006
[TBL] [Abstract][Full Text] [Related]
44. Application of pharmacoeconomics to formulary management in a health system setting.
Studdert AL; Gong CL; Srinivas S; Chin AL; Deresinski S
Am J Health Syst Pharm; 2019 Feb; 76(6):381-386. PubMed ID: 31361838
[TBL] [Abstract][Full Text] [Related]
45. How to develop a proactive formulary system.
Crane VS; Gonzalez ER; Hull BL
Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
[TBL] [Abstract][Full Text] [Related]
46. Use and misuse of pharmacoeconomic terms: a definitions primer.
Sanchez LA; Lee J
Top Hosp Pharm Manage; 1994 Jan; 13(4):11-22. PubMed ID: 10184005
[TBL] [Abstract][Full Text] [Related]
47. Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers.
Langley PC; Sullivan SD
J Manag Care Spec Pharm; 2020 Jun; 26(6):689-695. PubMed ID: 32463775
[TBL] [Abstract][Full Text] [Related]
48. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
[TBL] [Abstract][Full Text] [Related]
49. Formulary submission process catches on ... slowly.
Cross M
Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
[No Abstract] [Full Text] [Related]
50. Results of our national survey. Current formulary decision-making strategies and new factors influencing the process.
Formulary; 1995 Aug; 30(8):462-70. PubMed ID: 10151734
[TBL] [Abstract][Full Text] [Related]
51. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
[TBL] [Abstract][Full Text] [Related]
52. Formulary management to reduce cost: P & T committee strategies.
Roberts MJ; Summerfield MR
Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
[TBL] [Abstract][Full Text] [Related]
53. Applying decision analysis to pharmacy management and practice decisions.
Barr JT; Schumacher GE
Top Hosp Pharm Manage; 1994 Jan; 13(4):60-71. PubMed ID: 10130685
[TBL] [Abstract][Full Text] [Related]
54. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
Summers KH; Szeinbach SL
Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
[TBL] [Abstract][Full Text] [Related]
55. A call for fairness in formulary decisions.
Levinson W; Laupacis A
Arch Intern Med; 2006 Jan; 166(1):16-8. PubMed ID: 16401806
[No Abstract] [Full Text] [Related]
56. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
Fry RN; Avey SG; Sullivan SD
Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
[TBL] [Abstract][Full Text] [Related]
57. Formularies, therapeutics, and outcomes: new opportunities.
Fullerton DS; Atherly DS
Med Care; 2004 Apr; 42(4 Suppl):III39-44. PubMed ID: 15026670
[TBL] [Abstract][Full Text] [Related]
58. Using economic evaluations to make formulary coverage decisions. So much for guidelines.
Anis AH; Gagnon Y
Pharmacoeconomics; 2000 Jul; 18(1):55-62. PubMed ID: 11010604
[TBL] [Abstract][Full Text] [Related]
59. Use of centrally developed pharmacoeconomic assessments for local formulary decisions.
Tordoff JM; Murphy JE; Norris PT; Reith DM
Am J Health Syst Pharm; 2006 Sep; 63(17):1613-8. PubMed ID: 16914631
[TBL] [Abstract][Full Text] [Related]
60. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Weekes LM; Day RO
Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
